Notch Therapeutics appoints Kamran Alam as CFO and Gregory Block as SVP, Corporate Development

Ontario Industry Updates
Written By Maura Campbell
notch-logo.png

Notch Therapeutics Inc., a cell therapy company with a proprietary platform for generating renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Kamran Alam as Executive Vice President, Finance and Chief Financial Officer and Gregory Block as Senior Vice President, Corporate Development, effective immediately.

Maura Campbell
Previous

OBIO Announces National Call to Canadian Health Science Companies for Applications for the 2021 OBIO Investment Summit
Next

Joint Pathology Center selects Huron Digital Pathology’s image search engine